Global Testosterone Undecanoate Market Research Report 2023

Publication ID:

PB510233797

Publication Date:

October 9, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Testosterone undecanoate, sold under the brand names Nebido, Aveed, and Andriol among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men. It is taken by mouth two to three times per day with food or given by injection into muscle once every 12 weeks or so.
The global Testosterone Undecanoate market is projected to reach US$ 827.4 million in 2029, increasing from US$ 564 million in 2022, with the CAGR of 6.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Testosterone Undecanoate 91制片厂.
Key manufacturers engaged in the Testosterone Undecanoate industry include Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Zhejiang Xianju Pharmaceutical and Zhejiang Medicine Co., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Testosterone Undecanoate were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Testosterone Undecanoate market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Testosterone Undecanoate market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine Co.
Segment by Type
Injection
Oral
Segment by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Testosterone Undecanoate report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Testosterone Undecanoate Market Overview
1.1 Product Overview and Scope of Testosterone Undecanoate
1.2 Testosterone Undecanoate Segment by Type
1.2.1 Global Testosterone Undecanoate Market Value Comparison by Type (2023-2029)
1.2.2 Injection
1.2.3 Oral
1.3 Testosterone Undecanoate Segment by Application
1.3.1 Global Testosterone Undecanoate Market Value by Application: (2023-2029)
1.3.2 Primary Hypogonadism
1.3.3 Hypogonadotropic Hypogonadism
1.3.4 Late-Onset Hypogonadism
1.4 Global Testosterone Undecanoate Market Size Estimates and Forecasts
1.4.1 Global Testosterone Undecanoate Revenue 2018-2029
1.4.2 Global Testosterone Undecanoate Sales 2018-2029
1.4.3 Global Testosterone Undecanoate Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Testosterone Undecanoate Market Competition by Manufacturers
2.1 Global Testosterone Undecanoate Sales Market Share by Manufacturers (2018-2023)
2.2 Global Testosterone Undecanoate Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Testosterone Undecanoate Average Price by Manufacturers (2018-2023)
2.4 Global Testosterone Undecanoate Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Testosterone Undecanoate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Testosterone Undecanoate, Product Type & Application
2.7 Testosterone Undecanoate Market Competitive Situation and Trends
2.7.1 Testosterone Undecanoate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Testosterone Undecanoate Players Market Share by Revenue
2.7.3 Global Testosterone Undecanoate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Testosterone Undecanoate Retrospective Market Scenario by Region
3.1 Global Testosterone Undecanoate Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Testosterone Undecanoate Global Testosterone Undecanoate Sales by Region: 2018-2029
3.2.1 Global Testosterone Undecanoate Sales by Region: 2018-2023
3.2.2 Global Testosterone Undecanoate Sales by Region: 2024-2029
3.3 Global Testosterone Undecanoate Global Testosterone Undecanoate Revenue by Region: 2018-2029
3.3.1 Global Testosterone Undecanoate Revenue by Region: 2018-2023
3.3.2 Global Testosterone Undecanoate Revenue by Region: 2024-2029
3.4 North America Testosterone Undecanoate Market Facts & Figures by Country
3.4.1 North America Testosterone Undecanoate Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Testosterone Undecanoate Sales by Country (2018-2029)
3.4.3 North America Testosterone Undecanoate Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Testosterone Undecanoate Market Facts & Figures by Country
3.5.1 Europe Testosterone Undecanoate Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Testosterone Undecanoate Sales by Country (2018-2029)
3.5.3 Europe Testosterone Undecanoate Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Testosterone Undecanoate Market Facts & Figures by Country
3.6.1 Asia Pacific Testosterone Undecanoate Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Testosterone Undecanoate Sales by Country (2018-2029)
3.6.3 Asia Pacific Testosterone Undecanoate Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Testosterone Undecanoate Market Facts & Figures by Country
3.7.1 Latin America Testosterone Undecanoate Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Testosterone Undecanoate Sales by Country (2018-2029)
3.7.3 Latin America Testosterone Undecanoate Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Testosterone Undecanoate Market Facts & Figures by Country
3.8.1 Middle East and Africa Testosterone Undecanoate Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Testosterone Undecanoate Sales by Country (2018-2029)
3.8.3 Middle East and Africa Testosterone Undecanoate Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Testosterone Undecanoate Sales by Type (2018-2029)
4.1.1 Global Testosterone Undecanoate Sales by Type (2018-2023)
4.1.2 Global Testosterone Undecanoate Sales by Type (2024-2029)
4.1.3 Global Testosterone Undecanoate Sales Market Share by Type (2018-2029)
4.2 Global Testosterone Undecanoate Revenue by Type (2018-2029)
4.2.1 Global Testosterone Undecanoate Revenue by Type (2018-2023)
4.2.2 Global Testosterone Undecanoate Revenue by Type (2024-2029)
4.2.3 Global Testosterone Undecanoate Revenue Market Share by Type (2018-2029)
4.3 Global Testosterone Undecanoate Price by Type (2018-2029)
5 Segment by Application
5.1 Global Testosterone Undecanoate Sales by Application (2018-2029)
5.1.1 Global Testosterone Undecanoate Sales by Application (2018-2023)
5.1.2 Global Testosterone Undecanoate Sales by Application (2024-2029)
5.1.3 Global Testosterone Undecanoate Sales Market Share by Application (2018-2029)
5.2 Global Testosterone Undecanoate Revenue by Application (2018-2029)
5.2.1 Global Testosterone Undecanoate Revenue by Application (2018-2023)
5.2.2 Global Testosterone Undecanoate Revenue by Application (2024-2029)
5.2.3 Global Testosterone Undecanoate Revenue Market Share by Application (2018-2029)
5.3 Global Testosterone Undecanoate Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Corporation Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Testosterone Undecanoate Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bayer AG Testosterone Undecanoate Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 Endo Pharmaceuticals
6.2.1 Endo Pharmaceuticals Corporation Information
6.2.2 Endo Pharmaceuticals Description and Business Overview
6.2.3 Endo Pharmaceuticals Testosterone Undecanoate Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Endo Pharmaceuticals Testosterone Undecanoate Product Portfolio
6.2.5 Endo Pharmaceuticals Recent Developments/Updates
6.3 Merck Sharp & Dohme
6.3.1 Merck Sharp & Dohme Corporation Information
6.3.2 Merck Sharp & Dohme Description and Business Overview
6.3.3 Merck Sharp & Dohme Testosterone Undecanoate Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merck Sharp & Dohme Testosterone Undecanoate Product Portfolio
6.3.5 Merck Sharp & Dohme Recent Developments/Updates
6.4 Taro Pharmaceutical
6.4.1 Taro Pharmaceutical Corporation Information
6.4.2 Taro Pharmaceutical Description and Business Overview
6.4.3 Taro Pharmaceutical Testosterone Undecanoate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Taro Pharmaceutical Testosterone Undecanoate Product Portfolio
6.4.5 Taro Pharmaceutical Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Corporation Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Testosterone Undecanoate Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Cipla Testosterone Undecanoate Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Zhejiang Xianju Pharmaceutical
6.6.1 Zhejiang Xianju Pharmaceutical Corporation Information
6.6.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.6.3 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Product Portfolio
6.6.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.7 Zhejiang Medicine Co.
6.6.1 Zhejiang Medicine Co. Corporation Information
6.6.2 Zhejiang Medicine Co. Description and Business Overview
6.6.3 Zhejiang Medicine Co. Testosterone Undecanoate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zhejiang Medicine Co. Testosterone Undecanoate Product Portfolio
6.7.5 Zhejiang Medicine Co. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Testosterone Undecanoate Industry Chain Analysis
7.2 Testosterone Undecanoate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Testosterone Undecanoate Production Mode & Process
7.4 Testosterone Undecanoate Sales and Marketing
7.4.1 Testosterone Undecanoate Sales Channels
7.4.2 Testosterone Undecanoate Distributors
7.5 Testosterone Undecanoate Customers
8 Testosterone Undecanoate Market Dynamics
8.1 Testosterone Undecanoate Industry Trends
8.2 Testosterone Undecanoate Market Drivers
8.3 Testosterone Undecanoate Market Challenges
8.4 Testosterone Undecanoate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine Co.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.